Events

 

Meet us at the American Urological Association's Annual Meeting (AUA 2017)
Visit our booth #449 and join us for an oral presentation - abstract 17-1339
Convention Center in Boston, MA,
 May 12-16, 2017 

Join us at the  Meeting of the US and Canadian Academy of Pathology (USCAP 2017)
Visit our booth #708 and learn more about using CellDetect in your laboratory
Henry B. Gonzalez Convention Center in San Antonio, TX, 
March 6-8, 2017 

Meet us at the International Conference of Medical Innovation (MEDinISRAEL 2017)
Visit our booth #D60 to explore potential collaboration

Convention Center, Tel Aviv, Israel, March 7-8, 2017

Join us at the 40th European Congress of Cytology (ECC 2016)
For the presentation of a reproducibility study of CellDetect Bladder - oral abstract 30

Liverpool, UK, Oct 2-5, 2016 

Meet us at the Meeting of the College of American Pathologists (CAP16)
Visit our booth #202 and learn about CellDetect for bladder cancer diagnosis

Wynn/Encore, Las Vegas, NV, Sept 25-28, 2016

Join us at the Meeting of the American Academy of Oral Medicine (AAOM 2016)
For the presentation of the BRONJ risk stratification test - oral abstract OI0732

Atlanta, GA, April 4-9, 2016

Join us at the 31th Congress of the European Association of Urology (EAU 2016)
For the poster presentation of CellDetect for bladder cancer diagnosis - abstract 751

Munich, Germany, March 11-15, 2016 


News

 
27-11-2016
An extraordinary assembly of Micromedic's shareholders is scheduled on January 3rd, 2017 at 4pm in the Company's offices in Kyriat Atidim

24-11-2016
Micromedic announces approval to conduct an extended clinical study with CellDetect on prostate cancer diagnosis

19-7-2016
Announcement of an extraordinary assembly of shareholders of Micromedic Technologies

26-5-2016
Announcement of the annual general assembly of shareholders of Micromedic Technologies

10-1-2016
Micromedic Announces Receipt of Regulatory Approval to Commercialize CellDetect® Bladder Cancer Monitoring Kit in Israel

29-11-2015
Micromedic Announces Cooperation with Axella Research for Financing and Execution of Clinical and Regulatory Activities Required for FDA Approval of CellDetect® Bladder Cancer Monitoring

1-9-2015
Micromedic Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of BRONJ

30-6-2015
Micromedic Obtains EU CE Mark for CellDetect® Non-Invasive Test for Detecting Recurrence of Bladder Cancer

2-2-2015
Micromedic Reports Successful Clinical Study Results for Monitoring Bladder Cancer Recurrence

1-7-2014
Micromedic Reports Successful Interim Results from Bladder Cancer Clinical Study

 
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi